Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Rheumatol. 2019 Nov 15;47(7):1019–1025. doi: 10.3899/jrheum.181365

Table 3.

Odds ratio (OR) [95% confidence interval (CI)] for the association of restless sleep (a single item) using the Center for Epidemiology Study of Depression (CES-D) with knee pain outcomes stratified by baseline widespread pain status in the Multicenter Osteoarthritis Study

Restless sleep in past week in the CES-D
Knee pain outcomes More than 3-4 days (Referent group) 1-2 days < 1 day p-trend
Consistent frequent knee pain
Cross-sectional association for prevalent consistent frequent knee pain (N=4640)
  Knee (n/N) 475/1050 (29.6%) 626/1948 (39.0%) 504/1642 (31.4%)
  OR (95% CI) 1.0 (ref) 0.73 (0.60, 0.89) 0.76 (0.61, 0.94) 0.03

Longitudinal association for incident consistent frequent knee pain (N=2646)
  Knee (n/N) 122/497 (24.4%) 221/1178 (44.1%) 158/971 (31.5%)
  OR (95% CI) 1.0 (ref) 0.91 (0.60, 1.37) 1.14 (0.70, 1.84) 0.35

Knee pain worsening (N=4658)
Widespread pain absence (N=2746)
  Knee (n/N) 81/434 (18.7%) 253/1174 (21.6%) 216/1138 (19.0%)
  OR (95% CI) 1.0 (ref) 1.33 (0.93, 1.91) 1.11 (0.75, 1.63) 0.85

Widespread pain presence (N=1912)
  Knee (n/N) 222/618 (35.9%) 243/780 (31.1%) 157/514 (30.5%)
  OR (95% CI) 1.0 (ref) 0.78 (0.59 1.02) 0.73 (0.53, 1.00) 0.05
1

Number of knees: n (knees with pain worsening or incident joint pain) / N (total number of knees)

2

Model adjusted for age (years), sex (men vs. women), race (white vs. non-white), study site, BMI (kg/m2), education level (college and above vs. below college), tobacco use (pack-years), Charlson’s comorbidity index (range 0-9), fatigue (10-point scale), CES-D depression indicator (yes, no), and prescription use of NSAIDs (yes, no).